• Add this page to "Favorite pages"
  • Print the text(Open link in a new browser window)
Here begins the text.

Japanese Pharmacopoeia 17th Edition

  • JP 17th Edition Supplement I
    [December 1, 2017, the MHLW Ministerial Notification No.348]
  • JP 17th Edition Supplement II
    [June 28, 2019, the MHLW Ministerial Notification No.49]
    Note: Only original Japanese version is available (Japanese 17th edition Supplement II). *Linked to MHLW website
    Translation to English is in progress.

 

N.B.: The Japanese Pharmacopoeia Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs, General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia.(See the General Notices 5.)

 

JCN 3010005007409

Shin-Kasumigaseki Building, 3-3-2 Kasumigaseki,
Chiyoda-ku, Tokyo 100-0013 Japan

  • Contact us
  • Access/Map

Copyright (C) Pharmaceuticals and Medical Devices Agency, All Rights Reserved.

000043593
0
Japanese Pharmacopoeia 17th Edition
/english/rs-sb-std/standards-development/jp/0019.html
en